Company Creo Medical Group PLC

Equities

CREO

GB00BZ1BLL44

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 09:05:16 25/06/2024 pm IST 5-day change 1st Jan Change
32.25 GBX -1.53% Intraday chart for Creo Medical Group PLC -7.86% -29.89%

Business Summary

Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.

Number of employees: 279

Sales per Business

GBP in Million2022Weight2023Weight Delta
Electrosurgical Medical Devices
100.0 %
27 100.0 % 31 100.0 % +13.36%

Sales per region

GBP in Million2022Weight2023Weight Delta
Europe
67.2 %
19 70.3 % 21 67.2 % +8.38%
United Kingdom
30.8 %
8 28.6 % 10 30.8 % +22.11%
Rest of World
1.9 %
0 1.1 % 1 1.9 % +106.90%

Managers

Managers TitleAgeSince
Founder - -
Chief Executive Officer - 01/12/01
President - -
Director of Finance/CFO - 01/16/01
Director/Board Member - -

Members of the board

Members of the board TitleAgeSince
Chairman 59 01/16/01
Director/Board Member 60 -
Chief Executive Officer - 01/12/01
Director of Finance/CFO - 01/16/01
Director/Board Member - -
Founder - -
Director/Board Member 55 01/20/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 361,476,442 286,088,127 ( 79.14 %) 0 79.14 %

Shareholders

NameEquities%Valuation
Canaccord Genuity Wealth Ltd.
10.48 %
37,884,511 10.48 % 18 M p
Amati Global Investors Ltd.
4.346 %
15,708,915 4.346 % 7 M p
Welsh Development Agency
3.977 %
14,376,727 3.977 % 7 M p
Baillie Gifford & Co.
3.468 %
12,537,441 3.468 % 6 M p
SVM Asset Management Ltd.
2.939 %
10,623,907 2.939 % 5 M p
AXA Investment Managers UK Ltd.
2.211 %
7,992,961 2.211 % 4 M p
Chelverton Asset Management Ltd.
2.075 %
7,500,000 2.075 % 3 M p
Tellworth Investments LLP
1.597 %
5,772,778 1.597 % 3 M p
4,816,413 1.332 % 2 M p
Octopus Investments Ltd.
1.024 %
3,700,000 1.024 % 2 M p

Company contact information

Creo Medical Group Plc

Creo House Beaufort Park Way

NP16 5UH, Chepstow

+44 12 9160 6005

http://www.creomedical.com
address Creo Medical Group PLC(CREO)

Group companies

NameCategory and Sector
Medical Specialties

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3225 GBP
Average target price
0.895 GBP
Spread / Average Target
+177.52%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CREO Stock
  4. Company Creo Medical Group PLC